Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Felix Biotechnology has been awarded a Small Business Innovation Research (SBIR) Phase I grant for $314,411 from the National Institute of Health...
Felix Biotechnology — a biopharmaceutical company focused on developing first-in-class, durable, antibacterial therapies to treat chronic...
Felix Biotechnology — a biotechnology company focused on developing first-in-class, accessible, antibacterial therapies to treat drug-resistant...
The National Science Foundation (NSF) awarded Felix Biotechnology a Small Business Innovation Research (SBIR) Phase I grant for $256,000 to further...
Felix Biotechnology today announced the initiation of a research project with Biocogent, the leading provider of high technology products and...
Felix Biotechnology today announced the initiation of CYPHY, a Phase 1/2 investigator-initiated single center trial at Yale University for targeted...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.